Assessment of imprecision in gamma interferon release assays for the detection of exposure to mycobacterium tuberculosis

Clinical and Vaccine Immunology

Volumn 17, Issue 4, 2010, Pages 596-601

  Tuuminen, Tamara ^a,b   Tavast, Esko ^a   Väisänen, Riitta ^b   Himberg, Jaakko Juhani ^b   Seppälä, Ilkka ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BACTERIUM DETECTION; BCG VACCINATION; BLOOD SAMPLING; CASE REPORT; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GAMMA INTERFERON RELEASE ASSAY; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOREACTIVITY; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; TUBERCULOSIS; TUBERCULOUS SPONDYLITIS;

FEMALE; HUMANS; IMMUNOASSAY; INTERFERON-GAMMA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY OF RESULTS; TUBERCULOSIS;

EID: 77950632308     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00320-09     Document Type: Article

References (14)

1. Bayer HealthCare. 2003. Advia 60 manual. Bayer HealthCare, Tarrytown, NY.
2. Carrara, S., D. Vincenti, N. Petrosillo, M. Amicosante, E. Girardi, and D. Goletti. 2004. Use of T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin. Infect. Dis. 38:754-756.
3. Detjen, A. K., L. Loebenberg, H. M. S. Greval, K. Stanley, A. Gutschmidt, C. Kruger, N. Du Plessis, M. Kidd, N. Beyrs, G. Walzi, and A. C. Hesseling. 2009. Short-term reproducibility of a commercial interferon gamma release assay. Clin. Vaccine Immunol. 16:1170-1175.
4. Herrmann, J.-L., M. Belloy, R. Porcher, N. Simonney, R. Aboutaam, M. Lebourgeois, J. Gaudelus, L. De Losangeles, K. Chadelat, P. Schneinmann, N. Beydon, B. Fauroux, M. Bingen, M. Terki, D. Barraud, P. Cruaud, C. Offredo, A. Ferroni, P. Berche, D. Moissenet, H. Vuthien, C. Doit, E. Bingen, and P. H. Lagrange. 2009. Temporal dynamics of interferon gamma responses in children evaluated for tuberculosis. PLoS One 4:e4130.
5. Janetzki, S., S. Schaed, N. E. Blachere, L. Ben-Porat, A. N. Houghton, and K. S. Panageas. 2004. Evaluation of elispot assays: influence of method and operator on variability of results. J. Immunol. Methods 291:175-183.
6. Krouwer, J. S., and R. Rabinowitz. 1984. How to improve estimates of imprecision. Clin. Chem. 30:290-292.
7. Menzies, D., M. Pai, and G. Comstock. 2007. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med. 14:340-354.
8. Oxford Immunotec. 2009. T-SPOT.TB package insert. Oxford Immunotec, Marlborough, MA. http://www.oxfordimmunotec.com/USpageinsert.
9. Pai, M., and R. O'Brien. 2007. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions. PLoS One 4:e208.
10. Pai, M., A. Zwerling, and D. Menzies. 2008. Systematic review: T-cell-based assays for the diagnostics of latent tuberculosis infection: an update. Ann. Intern. Med. 149:177-184.
11. Tavast, E., I. Seppala, E. Salo, and T. Tuuminen. 2009. IGRA tests perform similarly to TST but cause no adverse reactions: pediatric experience in Finland. BMC Res. Notes 2:9
12. The TDR Diagnostics Evaluation Expert Panel. 2006. Evaluation of diagnostic tests for infectious diseases: general principles. Nat. Rev. Microbiol. 4:S20-S32.
13. Tuuminen, T., S. Sorva, K. Liippo, T. Vasankari, H. Soini, B. Eriksen-Neuman, A. Miettinen, and I. Seppala. 2007. Feasibility aspects of commercial interferon (IFN)-7 based methods for the diagnosis of latent Mycobacterium tuberculosis infection in Finland, a country of low incidence and high BCG vaccination coverage. Clin. Microb. Infect. 13:836-838.
14. Veerapathran, A., R. Joshi, K. Goswami, S. Dogra, E. E. Modie, M. V. Reddy, S. Kalantri, K. Schwartzman, M. A. Behr, D. Menzies, and M. Pai. 2008. T-cell assays for tuberculosis infection: deriving cutoffs for conversion using reproducibility data. PLoS One 3:e1850.